Skip to search formSkip to main contentSkip to account menu

Reviparin sodium

Known as: reviparin-sodium 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

reviparin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Heparin-induced thrombocytopenia with iliacofemoropopliteal thrombosis in a patient operated for colorectal carcinoma liver metastases.
We report a case of heparin-induced thrombocytopenia thrombosis (HITT) syndrome in a patient prophylactically treated with low… 
2009
2009
Pancreaticoduodenectomy: Perioperative Management and Technical Notes
Intestinal preparation is not routinely performed at our centre. Preoperative parenteral nutrition is only administered to… 
Review
2004
Review
2004
Reviparin sodium clivarine: a review of its therapeutic use.
Reviparin sodium (clivarine) is a second generation LMWH, developed with the aim of maximising the antithrombotic action while… 
2002
2002
Low-Molecular-Weight Heparin in Arterial Reconstructive Surgery: A Double-Blind, Randomized Dose-Finding Trial
Periprocedural and postprocedural anticoagulation during arterial reconstructive surgery (ARS) with intravenous heparin is… 
Review
2002
Review
2002
Reviparin sodium – a new low molecular weight heparin
Reviparin sodium (Clivarine®, Knoll AG) is a low molecular weight heparin (LMWH) with a mean peak molecular weight of 3900 Da. It… 
2001
2001
Antithrombotic Efficacy in a Rat Model of the Low Molecular Weight Heparin, Reviparin Sodium, Administered by the Oral Route
Summary Previous studies in rats show that unfractionated heparin and the low molecular weight heparin logiparin have a dose… 
Review
2001
Review
2001
Reviparin: a review of its efficacy in the prevention and treatment of venous thromboembolism.
UNLABELLED Reviparin (reviparin sodium) is a low molecular weight heparin (LMWH) that catalyses the inactivation of factors Xa… 
2001
2001
Reviparin sodium promotes thrombus regression in DVT
  • 2001
  • Corpus ID: 195156332
Review
1996
Review
1996
Cost-effectiveness of the low molecular weight heparin reviparin sodium in thromboprophylaxis.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)